Company news
Adagio Medical Holdings, Inc (NASDAQ:ADGM) news
Adagio Medical Holdings, Inc news releases on 6ix. Latest, Sep 23, 2026: Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value
Press releases & updates
Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value
September 23, 2026
Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner – University Medical Center Phoenix
September 16, 2026
Adagio Medical Reports Second Quarter 2026 Results
August 11, 2026
Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System
August 3, 2026
Adagio Medical : Amendment to Annual Report (Form 10-K/A)
July 13, 2026
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia
May 21, 2026
Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress
May 12, 2026
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference
April 29, 2026
Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System
April 26, 2026
Adagio Medical’s ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference
April 16, 2026
Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS Ventricular Ablation System
April 9, 2026
Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System
April 7, 2026
Adagio Medical to Participate in the 25th Annual Needham Virtual Conference
April 6, 2026
Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026
April 1, 2026
Adagio Medical Reports Fourth Quarter and Full Year 2025 Results
March 26, 2026
Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter
March 23, 2026
Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS System, Including Patients with Premature Ventricular Contractions (PVC)
March 20, 2026
Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)
March 18, 2026
Adagio Medical to Participate in the 38th Annual Roth Conference
March 11, 2026
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference
February 20, 2026
New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia
February 4, 2026
Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 2, 2026
Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th
January 30, 2026
Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness
December 22, 2025
Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors
December 11, 2025
Adagio Medical Reports Third Quarter 2025 Results
November 12, 2025
Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
November 5, 2025
Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
October 20, 2025
Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities
October 15, 2025
Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium
October 10, 2025
Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia
October 1, 2025
Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium
September 18, 2025
Adagio Medical Expands Chief Business Officer Deborah Kaster’s Role to Include Chief Financial Officer Responsibilities
September 8, 2025
Adagio Medical Reports Second Quarter 2025 Results
August 13, 2025
Adagio Medical Reports First Quarter 2025 Results
May 15, 2025
Adagio Medical to Present at the BofA Securities 2025 Health Care Conference
May 7, 2025
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
April 17, 2025
Adagio Medical Appoints Deborah Kaster as Chief Business Officer
March 31, 2025
Adagio Medical Reports Fourth Quarter and Full Year 2024 Results
March 31, 2025
Adagio Medical Provides Clinical and Business Updates
March 17, 2025
Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation
February 28, 2025
Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director
December 15, 2024
Adagio Medical Reports Third Quarter 2024 Results
November 13, 2024
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
October 23, 2024
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
October 6, 2024
Adagio Medical Provides Business Updates
August 18, 2024